Publications

Figure 3 from Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models

Authors: I Quiros-Gonzalez, MR Tomaszewski, MA Golinska, E Brown, L Ansel-Bollepalli...

E-pub date: 24 Nov 2025

Journal name:

Figure 2 from Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models

Authors: I Quiros-Gonzalez, MR Tomaszewski, MA Golinska, E Brown, L Ansel-Bollepalli...

E-pub date: 24 Nov 2025

Journal name:

Figure 1 from Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models

Authors: I Quiros-Gonzalez, MR Tomaszewski, MA Golinska, E Brown, L Ansel-Bollepalli...

E-pub date: 24 Nov 2025

Journal name:

Figure 4 from Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models

Authors: I Quiros-Gonzalez, MR Tomaszewski, MA Golinska, E Brown, L Ansel-Bollepalli...

E-pub date: 24 Nov 2025

Journal name:

Figure 5 from Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models

Authors: I Quiros-Gonzalez, MR Tomaszewski, MA Golinska, E Brown, L Ansel-Bollepalli...

E-pub date: 24 Nov 2025

Journal name:

Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer

Authors: DR Barnes, JP Tyrer, J Dennis, G Leslie, MK Bolla, M Lush, AM Aeilts, K Ait...

E-pub date: 20 Nov 2025

Journal name: NPJ Genom Med

The tumor microenvironment of 14,837 breast cancers is associated with clinical outcome independently of genomic subtypes.

Authors: KJ Tu, D Guerrero-Romero, K Eason, R Manzano Garcia, J Wern, S-H Teo, L Ngu...

E-pub date: 18 Nov 2025

Journal name: Cell Rep Med

Developmental senescence profiling reveals Eda2r as a common mediator in the core senescence program

Authors: A Klein, DS Gonçalves, L Dulac, T Knauer-Meyer, M Durik, ASL Chan, MC Birl...

E-pub date: 2 Nov 2025

Journal name:

Filters

Research Groups

Core Facilities

Start date

End date

Figure 3 from Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models

Figure 2 from Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models

Figure 1 from Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models

Figure 4 from Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models

Figure 5 from Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models

Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer

The tumor microenvironment of 14,837 breast cancers is associated with clinical outcome independently of genomic subtypes.

Developmental senescence profiling reveals Eda2r as a common mediator in the core senescence program

Themes

Filters

Research Groups

Core Facilities

Start date

End date

Figure 3 from Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models

Figure 2 from Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models

Figure 1 from Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models

Figure 4 from Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models

Figure 5 from Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models

Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer

The tumor microenvironment of 14,837 breast cancers is associated with clinical outcome independently of genomic subtypes.

Developmental senescence profiling reveals Eda2r as a common mediator in the core senescence program